• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

18F-FDG PET/CT 总病灶糖酵解对卵巢癌术后患者的预后预测价值。

Prognostic predictive value of total lesion glycolysis from 18F-FDG PET/CT in post-surgical patients with epithelial ovarian cancer.

机构信息

Department of Nuclear Medicine, Union Hospital, Tongji Medical College of Huazhong University of Science and Technology, Hubei Province Key Laboratory of Molecular Imaging, Wuhan, China.

出版信息

Clin Nucl Med. 2013 Sep;38(9):715-20. doi: 10.1097/RLU.0b013e31829f57fa.

DOI:10.1097/RLU.0b013e31829f57fa
PMID:23856825
Abstract

PURPOSE

The aim of this study was to determine an optimal threshold method for the segmentation of malignant lesions from (18)F-FDG PET/CT images and to evaluate the prognostic value of the total lesion glycolysis in post-surgical patients with epithelial ovarian cancer.

METHODS

We retrospectively reviewed 47 patients with pathologically proven epithelial ovarian cancer who underwent (18)F-FDG PET/CT imaging after surgery. The follow-up time was 26.6 ± 19.8 months (ranged from 4 to 89 months). For each patient, every lesion was segmented by 2 thresholds with 3D-area growing algorithm, standard uptake value (SUV) 2.5, and background method. The detection rates were compared. The optimal threshold method was then used to calculate whole-body metabolic tumor volume (WBMTV) and whole-body total lesion glycolysis (WBTLG). The prognostic significance of SUV(max), WBMTV, WBTLG, and other pathological variables for overall survival were assessed by Cox proportional hazards regression analysis and Kaplan-Meier survival analysis.

RESULTS

A total of 142 metastatic lesions of 47 patients were confirmed by long-term clinical follow-up or pathological findings. The detection rates of the threshold SUV 2.5 and background methods were 37.32% (53/142) and 96.48% (137/142), respectively, which showed significant difference between the 2 methods (P < 0.005). In multivariate analysis, WBTLG, obtained from the background method, was an independent predictive factor associated with the prognosis (HR 1.043, 95% CI 1.01-1.078, P = 0.011), and none of the other factors had statistical association. Survival analysis also showed that the survival time was clearly shortened with WBTLG increasing (P < 0.001).

CONCLUSIONS

In this group of post-surgery patients with epithelial ovarian cancer, the background method could segment much more malignant lesions than SUV = 2.5 method, and WBTLG, obtained from this method, could be used as an independent prognostic factor.

摘要

目的

本研究旨在确定一种用于(18)F-FDG PET/CT 图像中恶性病变分割的最佳阈值方法,并评估上皮性卵巢癌术后患者总病变糖酵解(total lesion glycolysis,TLG)的预后价值。

方法

我们回顾性分析了 47 例经病理证实的上皮性卵巢癌患者的(18)F-FDG PET/CT 影像学资料,这些患者均在术后进行了检查。随访时间为 26.6±19.8 个月(4~89 个月)。对每位患者,使用 3D 面积生长算法、标准摄取值(standard uptake value,SUV)2.5 和背景方法对每个病灶进行 2 种阈值分割。比较检测率。然后使用最佳阈值方法计算全身代谢肿瘤体积(whole-body metabolic tumor volume,WBMTV)和全身总病变糖酵解(whole-body total lesion glycolysis,WBTLG)。采用 Cox 比例风险回归分析和 Kaplan-Meier 生存分析评估 SUV(max)、WBMTV、WBTLG 和其他病理变量对总生存的预后意义。

结果

47 例患者共确认 142 个转移病灶,这些病灶均经长期临床随访或病理检查证实。阈值 SUV 2.5 法和背景法的检出率分别为 37.32%(53/142)和 96.48%(137/142),两种方法之间存在显著差异(P<0.005)。多因素分析显示,背景法获得的 WBTLG 是与预后相关的独立预测因素(HR 1.043,95%CI 1.01~1.078,P=0.011),而其他因素均无统计学关联。生存分析也表明,WBTLG 增加与生存时间明显缩短相关(P<0.001)。

结论

在这组上皮性卵巢癌术后患者中,背景法较 SUV=2.5 法能分割更多的恶性病灶,且从该方法获得的 WBTLG 可作为独立的预后因素。

相似文献

1
Prognostic predictive value of total lesion glycolysis from 18F-FDG PET/CT in post-surgical patients with epithelial ovarian cancer.18F-FDG PET/CT 总病灶糖酵解对卵巢癌术后患者的预后预测价值。
Clin Nucl Med. 2013 Sep;38(9):715-20. doi: 10.1097/RLU.0b013e31829f57fa.
2
Quantitative metabolic parameters measured on F-18 FDG PET/CT predict survival after relapse in patients with relapsed epithelial ovarian cancer.在复发的上皮性卵巢癌患者中,F-18氟代脱氧葡萄糖正电子发射断层显像/计算机断层扫描(F-18 FDG PET/CT)所测量的定量代谢参数可预测复发后的生存情况。
Gynecol Oncol. 2015 Mar;136(3):498-504. doi: 10.1016/j.ygyno.2014.12.032. Epub 2014 Dec 31.
3
Correlation of F-FDG uptake on PET/CT with Ki67 immunohistochemistry in pre-treatment epithelial ovarian cancer.正电子发射断层显像/计算机断层扫描(PET/CT)上氟代脱氧葡萄糖(F-FDG)摄取与治疗前上皮性卵巢癌中Ki67免疫组化的相关性
Rev Esp Med Nucl Imagen Mol (Engl Ed). 2018 Mar-Apr;37(2):80-86. doi: 10.1016/j.remn.2017.07.005. Epub 2017 Aug 30.
4
Prognostic value of (18)F-FDG PET/CT volumetric parameters in recurrent epithelial ovarian cancer.(18)F-FDG PET/CT体积参数在复发性上皮性卵巢癌中的预后价值
Rev Esp Med Nucl Imagen Mol. 2016 Mar-Apr;35(2):88-95. doi: 10.1016/j.remn.2015.08.005. Epub 2015 Nov 2.
5
Prognostic value of metabolic tumor burden from (18)F-FDG PET in surgical patients with non-small-cell lung cancer.(18)F-FDG PET 代谢肿瘤负荷对非小细胞肺癌手术患者的预后价值。
Acad Radiol. 2013 Jan;20(1):32-40. doi: 10.1016/j.acra.2012.07.002. Epub 2012 Sep 19.
6
Prognostic value of whole-body metabolic tumour volume and total lesion glycolysis measured on ¹⁸F-FDG PET/CT in patients with extranodal NK/T-cell lymphoma.¹⁸F-FDG PET/CT 全身代谢肿瘤体积和总病灶糖酵解测量对结外 NK/T 细胞淋巴瘤患者的预后价值。
Eur J Nucl Med Mol Imaging. 2013 Sep;40(9):1321-9. doi: 10.1007/s00259-013-2443-6. Epub 2013 May 15.
7
Predictive value of (18)F-FDG PET/CT in restaging patients affected by ovarian carcinoma: a multicentre study.(18)F-FDG PET/CT对卵巢癌患者再分期的预测价值:一项多中心研究。
Eur J Nucl Med Mol Imaging. 2016 Mar;43(3):404-13. doi: 10.1007/s00259-015-3184-5. Epub 2015 Sep 18.
8
Prognostic Value of Volume-Based Positron Emission Tomography/Computed Tomography in Nasopharyngeal Carcinoma Patients after Comprehensive Therapy.基于体素的正电子发射断层扫描/计算机断层扫描对综合治疗后鼻咽癌患者的预后价值。
Contrast Media Mol Imaging. 2018 Feb 21;2018:1384281. doi: 10.1155/2018/1384281. eCollection 2018.
9
F-FDG PET/CT can predict chemosensitivity and proliferation of epithelial ovarian cancer via SUVmax value.F-FDG PET/CT可通过SUVmax值预测上皮性卵巢癌的化疗敏感性和增殖情况。
Jpn J Radiol. 2018 Sep;36(9):544-550. doi: 10.1007/s11604-018-0755-y. Epub 2018 Jun 25.
10
Prognostic importance of peritoneal lesion-to-primary tumour standardized uptake value ratio in advanced serous epithelial ovarian cancer.腹膜病灶与原发肿瘤标准化摄取值比值对晚期浆液性上皮性卵巢癌的预后意义。
Eur Radiol. 2018 May;28(5):2107-2114. doi: 10.1007/s00330-017-5194-0. Epub 2017 Dec 19.

引用本文的文献

1
Combination of circulating tumor cells and 18F-FDG PET/CT for precision diagnosis in patients with non-small cell lung cancer.循环肿瘤细胞与 18F-FDG PET/CT 联合应用于非小细胞肺癌患者的精准诊断。
Cancer Med. 2024 Sep;13(18):e70216. doi: 10.1002/cam4.70216.
2
Role of Positron Emission Tomography/Computed Tomography in Epithelial Ovarian Cancer.正电子发射断层扫描/计算机断层扫描在上皮性卵巢癌中的作用
Indian J Nucl Med. 2023 Oct-Dec;38(4):366-375. doi: 10.4103/ijnm.ijnm_42_22. Epub 2023 Dec 20.
3
Predicting epithelial ovarian cancer prognosis: correlation of posttreatment F-fluorodeoxyglucose positron emission tomography-computed tomography metabolic parameters, serum carbohydrate antigen, and human epididymis protein levels with overall survival.
预测上皮性卵巢癌预后:治疗后氟脱氧葡萄糖正电子发射断层扫描-计算机断层扫描代谢参数、血清糖类抗原及人附睾蛋白水平与总生存期的相关性
Quant Imaging Med Surg. 2024 Jan 3;14(1):972-985. doi: 10.21037/qims-23-859. Epub 2024 Jan 2.
4
Diagnosis and prognostic predictive value of delineation methods from F-FDG PET/CT and PET/MR in pancreatic lesion.F-FDG PET/CT和PET/MR成像中胰腺病变勾画方法的诊断及预后预测价值
Am J Nucl Med Mol Imaging. 2023 Dec 25;13(6):269-278. eCollection 2023.
5
Precision of quantitative parameters of F-FDG PET/CT in a rabbit VX2 tumor model.F-FDG PET/CT定量参数在兔VX2肿瘤模型中的准确性
Quant Imaging Med Surg. 2023 Jun 1;13(6):3816-3826. doi: 10.21037/qims-22-1079. Epub 2023 Apr 17.
6
EANM guideline on the role of 2-[F]FDG PET/CT in diagnosis, staging, prognostic value, therapy assessment and restaging of ovarian cancer, endorsed by the American College of Nuclear Medicine (ACNM), the Society of Nuclear Medicine and Molecular Imaging (SNMMI) and the International Atomic Energy Agency (IAEA).EANM 指南:2-[F]FDG PET/CT 在卵巢癌诊断、分期、预后价值、治疗评估和再分期中的作用,得到了美国核医学学院 (ACNM)、核医学与分子成像学会 (SNMMI) 和国际原子能机构 (IAEA) 的认可。
Eur J Nucl Med Mol Imaging. 2021 Sep;48(10):3286-3302. doi: 10.1007/s00259-021-05450-9. Epub 2021 Jul 3.
7
Diagnostic performance of PET/CT and PET/MR in the management of ovarian carcinoma-a literature review.PET/CT与PET/MR在卵巢癌管理中的诊断性能——一项文献综述
Abdom Radiol (NY). 2021 Jun;46(6):2323-2349. doi: 10.1007/s00261-020-02847-2. Epub 2020 Nov 11.
8
Correlations between circulating tumor cell phenotyping and 18F-fluorodeoxyglucose positron emission tomography uptake in non-small cell lung cancer.循环肿瘤细胞表型与非小细胞肺癌 18F-氟脱氧葡萄糖正电子发射断层扫描摄取的相关性。
J Cancer Res Clin Oncol. 2020 Oct;146(10):2621-2630. doi: 10.1007/s00432-020-03244-4. Epub 2020 Jul 13.
9
F-FDG PET/CT in diagnostic and prognostic evaluation of patients with cardiac masses: a retrospective study.F-FDG PET/CT在心脏肿块患者诊断和预后评估中的应用:一项回顾性研究
Eur J Nucl Med Mol Imaging. 2020 May;47(5):1083-1093. doi: 10.1007/s00259-019-04632-w. Epub 2019 Dec 5.
10
The role of 18F-FDG PET/CT-based quantitative metabolic parameters in patients with ovarian clear cell carcinoma.18F-FDG PET/CT 基于定量代谢参数在卵巢透明细胞癌患者中的作用。
Cancer Biomark. 2020;27(2):189-194. doi: 10.3233/CBM-190904.